PARPi Response Prediction with Pillar Biosciences’ oncoReveal Geentic and Epigenetic Alteration Panels
Event Name: AMP 2021
TBC
Utilizing Pillar Biosciences’ Rapid oncoReveal 4-Gene Methylation Panel to Guide PARPi Therapy in Breast Cancer Patients
Event Name: AMP 2024
TBC
Looking Deeper into HRD to Inform PARP Inhibitor Therapy: Building the Case for NGS Methylation Testing
Publishing Entity: GenomeWeb | Precision Medicine Online